US Patent Issued to University of South Florida on March 31 for "N-Myc-interactor protein as a marker for chronic lung disease and uses thereof" (Florida Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,333, issued on March 31, was assigned to University of South Florida (Tampa, Fla.).

"N-Myc-interactor protein as a marker for chronic lung disease and uses thereof" was invented by Nirmal S. Sharma (Tampa, Fla.), Mudassir Banday (Tampa, Fla.) and Andreas Seyfang (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of predicting the development of chronic lung allograft dysfunction (CLAD) in lung transplant patients using N-myc-interactor (NMI) as a biomarker and associated treatment thereof is presented. Also presented is a method of reducing the risk of CLAD by administering a therapeutic agent capable of increasing NMI in the pati...